United States: FDA - Supply And Distribution Information Sharing

Last Updated: April 25 2014
Article by Michael A. Walsh

This is Why Humans Don't Like Lawyers: In February 2014, the Food and Drug Administration (FDA) opened a docket entitled "FDA's Standards for the Interoperable Exchange of TI, TH and TS Information for Tracing of Human Finished, Prescription Drugs." Translation: "help the FDA come up with a system to trace all drug products and their component parts."

FDA's docket sought comments to further its efforts to implement the Drug Supply Chain Security Act (DSCSA), which was signed into law on November 27, 2013. The new law provides for building an electronic "interoperable" system to identify and trace certain prescription drugs as they are distributed in the United States. An "interoperable" system, is where all participants "in the drug supply chain will be able to communicate with each other and share information about the drug and its location." See FDA Blog.

The new law requires the creation and implementation of a drug tracking information system within 10 years. When fully implemented, the new system will allow for tracking specific packages of drugs in the supply chain. The FDA's goal with this new system is to improve its ability to detect and recall illegitimate products. Under the new law, manufacturers, wholesale distributors, repackagers, and pharmacies are required to maintain product tracing data, and to quarantine and investigate suspect or illegitimate drug products, including suspected counterfeits, unapproved drugs, or dangerous goods, such as a recalled drug products.

The interoperable system will require each participant in the drug supply and distribution system to exchange transaction information ("TI"), transaction history ("TH") and transaction statements ("TS").

The deadline for comments to the FDA was April 21, 2014, and a number of stakeholders responded providing a glimpse into what systems are in place today and the hurdles the DSCSA implementation faces. For example, according to the Pharmaceutical Distribution Security Alliance (PDSA):

No one in the supply chain currently exchanges transaction history or the transaction statement required by DSCSA. While manufacturers include much of what the Act requires there is work to be done to correlate the various fields of data and wholesalers rarely and dispensers rarely have lot numbers and are not equipped to include this information.

The comments further note that there is "variable 'interoperability'" in processes (i.e., not all participants in the supply chain are ready for the new law), including processes related to Advance Ship Notices, Database/Portal input, Drug Pedigree Messaging Standard, Electronic Invoices, Electronic Product Code Information Service, and Paper invoices and packing slips.

Pharmacies and wholesalers present a unique challenge, and will be required to make changes to modify systems and practices to support the exchange and maintenance of the transaction information, history and statements including lot level information. The National Association of Chain Drug Stores submitted comments on behalf of its members stating:

Chain pharmacies would like to move to an electronic format for conveying TI, TH, and TS by 2017-2018, or earlier if feasible. However, we recognize that not all pharmacies will be ready to do so in this time frame. In addition, pharmacies would need adequate time to adapt and to make needed changes to their internal computer systems and to work with their trading partners for testing and to assure workability between the systems.

While the DSCSA looks for implementation in January 2015, estimating the timeframe necessary to implement these system-wide changes is difficult to forecast, even for individual participants in the supply chain. Based on the following comments of the PDSA, in the near term, a uniform standard for exchanging information is not feasible:

No solution, even paper, is today capable of accommodating all of the information required as of Jan. 1, 2015. Many in the supply chain are estimating that it will take at least six months to implement the standards, and a majority has indicated that they are waiting on FDA guidance before finalizing their companies' proposed solutions. Given the importance of FDA guidance to stakeholders' ability to comply with the law, stakeholders respectfully ask FDA to release its final guidance in advance of the statutory deadline, understanding that building consensus across stakeholders to reach an interoperable solution that can be implemented in a reasonable timeframe is the foremost goal.

FDA's own timetable for implementation of the DSCSA, including issuance of a draft guidance by mid-2014, seems doubtful; but as new technologies and approaches develop and evolve, the goal of system wide transparency will eventually be achieved. For now, the timing set forth in DSCSA appears more aspirational than possible.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Michael A. Walsh
Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions